Scarica l'app Stockscreener
22.78
3.52%
-0.83
Dopo l'orario di chiusura:
22.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$23.61
Aprire:
$23.52
Volume 24 ore:
1.43M
Relative Volume:
1.20
Capitalizzazione di mercato:
$1.51B
Reddito:
$5.79M
Utile/perdita netta:
$-199.61M
Rapporto P/E:
-7.5681
EPS:
-3.01
Flusso di cassa netto:
$-188.48M
1 W Prestazione:
+1.79%
1M Prestazione:
+4.50%
6M Prestazione:
+13.90%
1 anno Prestazione:
-48.85%
Intervallo 1D:
$22.34
$23.57
Intervallo di 1 settimana:
$21.71
$23.69
Portata 52W:
$14.40
$47.00
Celldex Therapeutics Inc Stock (CLDX) Company Profile
Nome
Celldex Therapeutics Inc
Settore
Industria
Telefono
908-200-7500
Indirizzo
53 FRONTAGE ROAD, HAMPTON
Confronta CLDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLDX
Celldex Therapeutics Inc
|
22.78 | 1.46B | 5.79M | -199.61M | -188.48M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-28 | Iniziato | Canaccord Genuity | Buy |
| 2025-03-20 | Iniziato | Morgan Stanley | Overweight |
| 2025-02-13 | Iniziato | UBS | Buy |
| 2024-10-07 | Iniziato | Citigroup | Buy |
| 2024-09-30 | Iniziato | Goldman | Neutral |
| 2024-09-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-18 | Iniziato | Stifel | Buy |
| 2024-06-11 | Iniziato | Wolfe Research | Outperform |
| 2023-12-20 | Iniziato | TD Cowen | Outperform |
| 2023-11-10 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-08-22 | Iniziato | Wells Fargo | Underweight |
| 2021-09-17 | Iniziato | Jefferies | Buy |
| 2021-09-10 | Iniziato | SVB Leerink | Outperform |
| 2021-07-22 | Iniziato | Guggenheim | Buy |
| 2020-02-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-08-01 | Ripresa | H.C. Wainwright | Buy |
| 2016-11-07 | Iniziato | Aegis Capital | Buy |
| 2016-03-08 | Downgrade | Jefferies | Buy → Hold |
| 2016-03-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2016-03-07 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2016-03-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2016-03-01 | Iniziato | H.C. Wainwright | Buy |
| 2015-08-11 | Reiterato | Brean Capital | Buy |
| 2015-08-11 | Reiterato | Oppenheimer | Outperform |
| 2015-08-11 | Reiterato | ROTH Capital | Buy |
| 2015-06-02 | Reiterato | WBB Securities | Strong Buy |
| 2014-11-17 | Reiterato | ROTH Capital | Buy |
| 2014-03-04 | Reiterato | Oppenheimer | Outperform |
| 2013-07-08 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-03-08 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-02-26 | Reiterato | Oppenheimer | Outperform |
| 2013-01-10 | Reiterato | Cantor Fitzgerald | Buy |
| 2012-10-02 | Reiterato | Oppenheimer | Outperform |
| 2012-09-14 | Reiterato | Cantor Fitzgerald | Buy |
Mostra tutto
Celldex Therapeutics Inc Borsa (CLDX) Ultime notizie
Does Celldex Therapeutics Inc. have high return on assetsTrade Entry Report & AI Powered Market Entry Ideas - khodrobank.com
Is Celldex Therapeutics Inc. gaining market shareJuly 2025 Fed Impact & AI Enhanced Trading Signals - khodrobank.com
What indicators show strength in Celldex Therapeutics Inc.Market Trend Review & High Conviction Buy Zone Picks - Newser
will a bounce in celldex therapeutics inc. offer an exitJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - Newser
Is a relief rally coming for Celldex Therapeutics Inc. holdersInsider Buying & AI Enhanced Trade Execution Alerts - Newser
Using economic indicators to assess Celldex Therapeutics Inc. potentialMarket Performance Summary & AI Forecasted Entry and Exit Points - Newser
Should I set a stop loss on Celldex Therapeutics Inc.Volume Spike & Verified Entry Point Signals - khodrobank.com
Is Celldex Therapeutics Inc. impacted by rising ratesMarket Sentiment Report & Comprehensive Market Scan Reports - khodrobank.com
Historical volatility pattern of Celldex Therapeutics Inc. visualizedAnalyst Upgrade & Community Supported Trade Ideas - Newser
What machine learning models say about Celldex Therapeutics Inc.Analyst Upgrade & Proven Capital Preservation Tips - Newser
Backtesting results for Celldex Therapeutics Inc. trading strategiesJuly 2025 Reactions & Community Supported Trade Ideas - Newser
Is Celldex Therapeutics Inc. stock entering bullish territoryJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser
How Celldex Therapeutics Inc. stock performs during market volatilityJuly 2025 Price Swings & Community Trade Idea Sharing Platform - Newser
Chart based exit strategy for Celldex Therapeutics Inc.2025 Technical Overview & Real-Time Buy Signal Alerts - Newser
What technical models suggest about Celldex Therapeutics Inc.’s comeback - Newser
Will a bounce in Celldex Therapeutics Inc. offer an exit2025 Market Overview & Consistent Income Trade Ideas - Newser
Is Celldex Therapeutics Inc. on track to beat earningsQuarterly Performance Summary & Entry and Exit Point Strategies - khodrobank.com
Published on: 2025-09-03 03:10:59 - khodrobank.com
Celldex Therapeutics Inc. Recovery Gathers Momentum on Chart SignalsQuarterly Market Review & Verified Momentum Stock Alerts - beatles.ru
Can you recover from losses in Celldex Therapeutics Inc.Insider Buying & Expert-Curated Trade Recommendations - Newser
Analyzing drawdowns of Celldex Therapeutics Inc. with statistical tools2025 Growth vs Value & Free Community Supported Trade Ideas - Newser
How to build a custom watchlist for Celldex Therapeutics Inc.2025 Pullback Review & Daily Stock Trend Reports - Newser
Is Celldex Therapeutics Inc. stock poised for growthJuly 2025 Summary & Proven Capital Preservation Methods - Newser
Celldex Therapeutics Inc. Could See a Relief Rally From Support getLinesFromResByArray error: size == 0 - kangso.co.kr
Celldex Therapeutics’ SWOT analysis: barzolvolimab stock potential amid setbacks - Investing.com
Can Celldex Therapeutics Inc. maintain sales growthJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - خودرو بانک
How to read the order book for Celldex Therapeutics Inc.Market Risk Analysis & Weekly High Return Opportunities - Newser
How to build a dashboard for Celldex Therapeutics Inc. stockTrade Performance Summary & Community Verified Watchlist Alerts - Newser
Analyzing recovery setups for Celldex Therapeutics Inc. investorsJuly 2025 Action & Weekly Setup with High ROI Potential - Newser
Published on: 2025-08-31 20:05:07 - Newser
Relief Rally in Celldex Therapeutics Inc. Stock — Can It Hold getLinesFromResByArray error: size == 0 - 더경남뉴스
Is Celldex Therapeutics Inc. stock bottoming outOil Prices & Capital Protection Trade Alerts - Newser
Using R and stats models for Celldex Therapeutics Inc. forecastingWeekly Trade Report & Weekly Sector Rotation Insights - Newser
Custom strategy builders for tracking Celldex Therapeutics Inc.Portfolio Update Report & Free Expert Verified Stock Movement Alerts - Newser
Celldex Therapeutics Inc. Shows Early Signs of Technical Strength2025 Volume Leaders & Precise Swing Trade Alerts - beatles.ru
Celldex Therapeutics Inc Azioni (CLDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Celldex Therapeutics Inc Azioni (CLDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Marucci Anthony S | PRESIDENT & CEO |
Nov 11 '24 |
Buy |
26.82 |
11,500 |
308,430 |
40,284 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):